CLINICAL TRIALS DATA MONITORING COMMITTEES
\klˈɪnɪkə͡l tɹˈa͡ɪə͡lz dˈe͡ɪtə mˈɒnɪtəɹɪŋ kəmˈɪtiz], \klˈɪnɪkəl tɹˈaɪəlz dˈeɪtə mˈɒnɪtəɹɪŋ kəmˈɪtiz], \k_l_ˈɪ_n_ɪ_k_əl t_ɹ_ˈaɪ_əl_z d_ˈeɪ_t_ə m_ˈɒ_n_ɪ_t_ə_ɹ_ɪ_ŋ k_ə_m_ˈɪ_t_i_z]\
Sort: Oldest first
-
Committees established to review interim data and efficacy outcomes in CLINICAL TRIALS. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects (the "Common Rule") require (45 CFR 46.111) that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations (21 CFR 50.24) require that such committees be established to monitor studies conducted in emergency settings.
By DataStellar Co., Ltd
Word of the day
Quinones
- Hydrocarbon rings which contain two moieties position. They can be substituted in any position except at the ketone groups.